Latest News

Archive 2006

12.11.06	Queen's University Study Results in Proof of Principle Data for Lead Cancer Drug
10.31.06	Memorial Sloan-Kettering Cancer Center to Test PharmaGap’s Cancer Drug
10.06.06	PharmaGap’s Cancer Drug Well Positioned
09.28.06	PharmaGap to Collaborate with Leading Medical Researcher
09.21.06	PharmaGap Drug Shown Effective Using Systemic IP Administration
09.18.06	PharmaGap Issues Additional Series 3 Notes
09.15.06	PharmaGap Signs Advisory Contract with Leading U.S. Cancer Researcher
09.06.06	Filing of Additional Core Technology Patents
06.20.06	PharmaGap Issues Additional Series 3 Notes
06.19.06	PharmaGap Launches Licensing Program for Lead Cancer Drug PhGalpha1
05.24.06	PharmaGap Retains Dundee Securities And Wellington West As Strategic Advisors To License Or Sell Lead Drug
05.04.06	PharmaGap Issues Additional Series 3 Notes
04.13.06	PharmaGap Confirms Efficacy Of Its Lead Drug Compound To Treat Chemo-Resistant Colorectal Cancer
04.12.06	PharmaGap Issues Additional Series 3 Notes
03.15.06	PharmaGap Retains Wellington West As Agent For $5 Million Private Placement
01.25.06	PharmaGap Releases Pre-Clinical Animal Efficacy Data For Lead Drug Compound For Oncology
01.17.06	PharmaGap Announces Approval For And Issuance Of Series 3 Notes